FDAFDA · Food and drugs·Recall number D-0508-2026
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.
Published May 6, 2026 · Recall initiated: April 1, 2026
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
cGMP deviations.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Wells Pharma of Houston LLC
- Distributor
- U.S. Nationwide.
- Lot
- Lot 020226202150202, Exp Date 05/05/2026.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.